Haemodialysis

Haemodialysis is an extracorporeal procedure to remove waste products from the blood, such as creatinine and urea, which are insufficiently removed by the kidneys in patients with renal failure. During the procedure, patients’ blood is withdrawn and cleansed by filtration through a series of membranes before being returned to the patient.

Latest Research and Reviews

News and Comment

  • Comments & Opinion |

    Living with chronic kidney disease (CKD) is not easy, and patients must adopt lifestyle changes that can be difficult. Owing to the complexities of the disease, patients must be supported to improve their understanding of CKD and to enable them to make informed decisions about the management of their disease.

    • John D. Ortiz
  • Comments & Opinion |

    Patients receiving dialysis are at high risk of contracting SARS-CoV-2 and developing severe COVID-19. Established SARS-CoV-2 vaccination schemes might lack efficacy in these patients and a personalized approach is therefore necessary. Importantly, given the enhanced infection risks associated with dialysis, current vaccines do not replace non-pharmacological measures to prevent infection.

    • Benjamin Wilde
    • , Johannes Korth
    •  & Andreas Kribben
  • Comments & Opinion |

    Venezuela is going through a humanitarian crisis that has severely impacted all programmes of kidney replacement therapy — dialysis coverage has decreased markedly, particularly in small towns and rural areas, and almost all peritoneal dialysis and deceased donor organ procurement for kidney transplantation have been discontinued.

    • Ezequiel Bellorin-Font
    •  & Raul G. Carlini
  • Comments & Opinion |

    Insomnia is common among patients on maintenance haemodialysis and may be exacerbated by the challenges of the COVID pandemic. However, data on the efficacy of insomnia interventions in this population are limited. Efforts are needed to address this important problem and increase access to insomnia interventions for patients on haemodialysis.

    • Daniel Cukor
    • , Mark Unruh
    •  & Rajnish Mehrotra
  • News & Views |

    A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution.

    • Viyaasan Mahalingasivam
    •  & Laurie Tomlinson